2019
DOI: 10.4330/wjc.v11.i8.200
|View full text |Cite
|
Sign up to set email alerts
|

One-year outcomes of a NeoHexa sirolimus-eluting coronary stent system with a biodegradable polymer in all-comers coronary artery disease patients: Results from NeoRegistry in India

Abstract: BACKGROUND Biodegradable polymer drug-eluting stents (BP-DES) have shown to reduce restenosis rates and have low rates of stent thrombosis. The present postmarketing surveillance assessed 1-year clinical outcomes of patients who had received NeoHexa DES in real practice. AIM To investigate 1-year clinical outcomes of Neohexa DES in real practice. METHODS Data obtained from a single-center cohort of patients who had received NeoHexa stents as … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…Percutaneous coronary intervention (PCI) is a frequently conducted cardiac procedure aimed at enhancing the quality of life and reducing symptoms for individuals suffering from coronary artery disease (CAD)[ 1 ]. CAD is the leading cause of mortality across the globe[ 2 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Percutaneous coronary intervention (PCI) is a frequently conducted cardiac procedure aimed at enhancing the quality of life and reducing symptoms for individuals suffering from coronary artery disease (CAD)[ 1 ]. CAD is the leading cause of mortality across the globe[ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…This has been achieved by incorporating innovative stent platform materials with thinner struts, utilizing biocompatible or biodegradable polymers with improved coatings, and implementing novel antiproliferative agents by lowering the content of drug and precisely controlling the rate of elution[ 4 ]. The advent of DES has decreased the rates of restenosis and become the preferred method of choice for most of the patients undergoing the procedure of PCI[ 1 ]. These stents have become widely used across a range of anatomic and clinical aspects due to their reduced rates of restenosis and the requirement for the repetition of the revascularization procedure[ 2 ].…”
Section: Introductionmentioning
confidence: 99%